Storebrand Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Storebrand Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-253,369	Closed	-$175K	–	839
2020 Q4	$175K	Hold	253,369	–	–	﹤0.01%	785
2020 Q3	$570K	Hold	253,369	–	–	﹤0.01%	715
2020 Q2	$907K	Hold	253,369	–	–	0.01%	659
2020 Q1	$963K	Buy	+253,369	New	+$835K	0.01%	619

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Storebrand Asset Management's BMY.RT Position: Q1 2021 in Review

Storebrand Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 253,369 shares — an estimated $175K sold.

Storebrand Asset Management first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $963K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Storebrand Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Storebrand Asset Management sold 253,369 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $175K.
Storebrand Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
Storebrand Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $963K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Storebrand Asset Management's 13F filing for Q1 2021, filed 18 Jun 2026.